In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors

P De Sarno, GN Bijur, AA Zmijewska, X Li… - Neurobiology of aging, 2006 - Elsevier
Glycogen synthase kinase-3 (GSK3), which is inhibited by serine-phosphorylation, is
involved in the neuropathology of Alzheimer's disease (AD). We tested if the two therapeutic …
被引用次数：101 相关文章

In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors

P De Sarno, GN Bijur, AA Zmijewska, X Li… - Neurobiology of …, 2006 - infona.pl
Glycogen synthase kinase-3 (GSK3), which is inhibited by serine-phosphorylation, is
involved in the neuropathology of Alzheimer's disease (AD). We tested if the two therapeutic …

[引用][C] IN VIVO REGULATION OF GSK3 PHOSPHORYLATION BY CHOLINERGIC AND NMDA RECEPTORS

P SARNO, N BIJUR, A ZMIJEWSKA - 2006 - sid.ir
[HTML] nih.gov

[HTML][HTML] In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors

P De Sarno, GN Bijur, AA Zmijewska, X Li… - Neurobiology of …, 2006 - ncbi.nlm.nih.gov
Abstract Glycogen synthase kinase-3 (GSK3), which is inhibited by serine-phosphorylation,
is involved in the neuropathology of Alzheimer's disease (AD). We tested if the two …

[引用][C] In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors

P De Sarno, GN Bijur, AA Zmijewska, X Li… - Neurobiology of …, 2006 - cir.nii.ac.jp
In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors

P De Sarno, GN Bijur, AA Zmijewska… - Neurobiology of …, 2006 - pubmed.ncbi.nlm.nih.gov
Glycogen synthase kinase-3 (GSK3), which is inhibited by serine-phosphorylation, is
involved in the neuropathology of Alzheimer's disease (AD). We tested if the two therapeutic …

In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors

P De Sarno, GN Bijur, AA Zmijewska… - Neurobiology of …, 2006 - scholarship.miami.edu
Glycogen synthase kinase-3 (GSK3), which is inhibited by serine-phosphorylation, is
involved in the neuropathology of Alzheimer's disease (AD). We tested if the two therapeutic …

In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors.

P De Sarno, GN Bijur, AA Zmijewska, X Li… - Neurobiology of …, 2005 - europepmc.org
Abstract Glycogen synthase kinase-3 (GSK3), which is inhibited by serine-phosphorylation,
is involved in the neuropathology of Alzheimer's disease (AD). We tested if the two …

[引用][C] In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors

DE SARNO - Neurobiol Aging, 2006 - cir.nii.ac.jp
In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …